Therapeutic use of specific ligand in MSRV associated diseases
    83.
    发明授权
    Therapeutic use of specific ligand in MSRV associated diseases 有权
    特异性配体在MSRV相关疾病中的治疗用途

    公开(公告)号:US08715656B2

    公开(公告)日:2014-05-06

    申请号:US12997486

    申请日:2009-07-08

    Abstract: The present invention deals with a ligand comprising each of the complementary-determining regions (CDRs) set forth in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 SEQ ID No. 4, SEQ ID No. 5 and SEQ ID No. 6 or sequence having either number of substituted aminoacids within said sequences as indicated in the following, from 0 to 3 in CDR1(SEQ ID No. 1), from 0 to 2 in CDR2(SEQ ID No. 2), from 0 to 2 in CDR3(SEQ ID No. 3), from 0 to 1 in CDR4(SEQ ID No. 4), from 0 to 4 in CDR5(SEQ ID No. 5), from 0 to 2 in CDR6(SEQ ID No. 6), or aminoacids substituted with other aminoacids having equivalent chemical functions and properties, within said sequences SEQ ID No. 1 to SEQ ID No. 6.

    Abstract translation: 本发明涉及包含SEQ ID No.1,SEQ ID No.2,SEQ ID No.3,SEQ ID No.4,SEQ ID No.5所示的每个互补决定区(CDR)和 SEQ ID No.6或在所述序列中具有任意数目的取代氨基酸的序列,如下所示,CDR1(SEQ ID No.1)中为0至3,CDR2(SEQ ID No.2)为0至2, 在CDR3(SEQ ID No.3)中为0至2,CDR4(SEQ ID No.4)为0至1,CDR5(SEQ ID No.5)为0至4,CDR6(SEQ ID NO:0)为0至2 SEQ ID NO:6),或在所述序列SEQ ID No.1至SEQ ID No.6内具有等同化学功能和性质的其它氨基酸取代的氨基酸。

    Gammaretrovirus associated with cancer
    86.
    发明授权
    Gammaretrovirus associated with cancer 失效
    与癌症相关的瘤胃病毒

    公开(公告)号:US08263085B2

    公开(公告)日:2012-09-11

    申请号:US11903756

    申请日:2007-09-24

    Abstract: The present invention provides for isolated nucleic acid sequences encoding viruses; isolated polypeptides comprising amino acid sequences of the virus; vectors comprising the viral nucleic acid sequences; cells comprising the vectors; antibodies and antigen binding fragments thereof which have binding specificity for the virus; methods of detecting or screening for the virus (e.g., in an individual); methods of identifying agents that inhibit the virus; methods of inducing an immune response to the virus; methods of treating disease associated with the presence of XMRV in an individual (e.g., cancer such as prostate cancer); methods of detecting asymptomatic cancer (e.g., prostate cancer); methods of identifying an individual at risk for developing cancer (e.g., prostate cancer); and kits for detecting the virus.

    Abstract translation: 本发明提供了编码病毒的分离的核酸序列; 包含病毒的氨基酸序列的分离的多肽; 包含病毒核酸序列的载体; 包含载体的细胞; 对病毒具有结合特异性的抗体及其抗原结合片段; 检测或筛选病毒的方法(例如,在个体中); 识别抑制病毒的药剂的方法; 诱导对病毒的免疫应答的方法; 治疗与个体(例如癌症如前列腺癌)中XMRV存在相关的疾病的方法; 检测无症状癌症的方法(例如前列腺癌); 识别患有癌症风险的个体(例如前列腺癌)的方法; 和用于检测病毒的工具包。

Patent Agency Ranking